GXP PHARMAID ApS: Financial statements 2018
CVR: 29615861
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
GXP PHARMAID ApS (CVR 29615861) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 1,148,568 and a net result of DKK 217,265 compared with DKK 142,289 the year before. That is a decrease of 18.6% compared with the year before. Equity in the 2018 report amounted to DKK 903,949. The solvency ratio was 48.5%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,148,568
- Profit/Loss
- DKK 217,265
- Equity
- DKK 903,949
- Total Assets
- DKK 1,863,521
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 1.1 mio. | 217 t. | 904 t. | 1 |
| 2017 | - | 1.4 mio. | 142 t. | 687 t. | 1 |
| 2016 | - | 1.6 mio. | 97 t. | 544 t. | - |
| 2015 | - | 1.9 mio. | -667 t. | 447 t. | - |
| 2014 | - | 3.6 mio. | 380 t. | 1.1 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
GXP PHARMAID ApS has published its annual report for 2017. Gross profit came to DKK 1,410,169, and the net result was DKK 142,289.
About GXP PHARMAID ApS
GXP PHARMAID ApS is a Danish company of the type Anpartsselskab based in Brønshøj, founded in 2006. The company is registered under the industry Anden teknisk rådgivning. The company was previously named Q-VIGILANCE ApS. The management consists of Nusret Asanovski. The company is owned by MAC ANDORBY ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,163,256 and a net result of DKK 122,320 compared with DKK 216,532 the year before. Equity in the 2025 report amounted to DKK 1,218,531.